INTERNATIONAL PATENT: TASLY PHARMACEUTICAL GROUP CO., LTD, 天士力医药集团股份有限公司 FILES APPLICATION FOR "MESENCHYMAL STROMAL CELL-BASED DRUG AND USE THEREOF IN TREATMENT OF ACUTE CEREBRAL INFARCTION"

GENEVA, May 9 -- TASLY PHARMACEUTICAL GROUP CO., LTD (Tasly Modern TCM Garden, Pu Jihe East Road No.2Beichen District, Tianjin 300410), 天士力医药集团股份有限公司 (中国天津市北辰区普济河东道2号（天士力现代中药城）) filed a patent application (PCT/CN2025/130282) for "MESENCHYMAL STROMAL CELL-BASED DRUG AND USE THEREOF IN TREATMENT OF ACUTE CEREBRAL INFARCTION" on Oct 27, 2025. With publication no. WO/2026/092393, the details related to the patent application was published on May 07, 2026.

Notably, the patent application wa...